Home
About
Overview
Sharing Data
ORCID
Help
History (26)
Sucralfate
Minimal Clinically Important Difference and Substantial Clinical Benefit Values for the 12-Item International Hip Outcome Tool.
Current Trends in Outpatient Spine Surgery.
Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response.
Therapeutic options for laryngeal cancer.
See All 26 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Therapeutic options for laryngeal cancer.
Therapeutic options for laryngeal cancer. N Engl J Med. 2003 Nov 27; 349(22):2087-9.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Humans
Laryngeal Neoplasms
Neoplasm Staging
authors with profiles
Kerstin Stenson